• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Glycoprotein IIb/IIIa inhibitors to facilitate percutaneous intervention in ST-elevation myocardial infarction: the sooner not necessarily the better.

作者信息

Guzman Luis A

出版信息

Circ J. 2010 Aug;74(8):1528-9. doi: 10.1253/circj.cj-10-0509. Epub 2010 Jul 14.

DOI:10.1253/circj.cj-10-0509
PMID:20647633
Abstract
摘要

相似文献

1
Glycoprotein IIb/IIIa inhibitors to facilitate percutaneous intervention in ST-elevation myocardial infarction: the sooner not necessarily the better.糖蛋白IIb/IIIa抑制剂用于促进ST段抬高型心肌梗死的经皮介入治疗：并非越早越好。
Circ J. 2010 Aug;74(8):1528-9. doi: 10.1253/circj.cj-10-0509. Epub 2010 Jul 14.
2
Impact of time-to-treatment on myocardial perfusion after primary percutaneous coronary intervention with Gp IIb-IIIa inhibitors.替罗非班对急性 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗后心肌灌注的影响
J Cardiovasc Med (Hagerstown). 2013 Nov;14(11):815-20. doi: 10.2459/JCM.0b013e32835fcb38.
3
Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE).非ST段抬高型心肌梗死患者接受经皮冠状动脉介入治疗时糖蛋白IIb/IIIa抑制剂的使用时机及预后（CRUSADE研究结果）
Am J Cardiol. 2007 May 15;99(10):1389-93. doi: 10.1016/j.amjcard.2006.12.066. Epub 2007 Mar 26.
4
Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis.急性ST段抬高型心肌梗死直接经皮冠状动脉介入治疗中糖蛋白IIb/IIIa抑制剂的早期与晚期给药：一项荟萃分析
JAMA. 2004 Jul 21;292(3):362-6. doi: 10.1001/jama.292.3.362.
5
Platelet glycoprotein IIb/IIIa blockers for percutaneous coronary revascularization, and unstable angina and non-ST-segment elevation myocardial infarction.用于经皮冠状动脉血运重建、不稳定型心绞痛及非ST段抬高型心肌梗死的血小板糖蛋白IIb/IIIa阻滞剂
Cochrane Database Syst Rev. 2001(4):CD002130. doi: 10.1002/14651858.CD002130.
6
A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials.比较直接经皮冠状动脉介入治疗中应用阿昔单抗与小分子糖蛋白Ⅱb/Ⅲa 抑制剂的疗效：当代随机对照试验的荟萃分析。
Circ Cardiovasc Interv. 2009 Jun;2(3):230-6. doi: 10.1161/CIRCINTERVENTIONS.108.847996. Epub 2009 Apr 21.
7
The benefits of platelet glycoprotein IIb/IIIa receptor inhibition during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: drug-specific or class effect?
J Am Coll Cardiol. 2009 May 5;53(18):1674-6. doi: 10.1016/j.jacc.2009.02.009.
8
[Glycoprotein IIb/IIIa platelet blockers in acute myocardial infarct treated with primary coronary angioplasty].[糖蛋白IIb/IIIa血小板阻滞剂在直接冠状动脉血管成形术治疗急性心肌梗死中的应用]
Vnitr Lek. 2002 Aug;48(8):736-41.
9
Clinical outcome of patients with diabetes presenting with ST-elevation myocardial infarction and treated with concomitant use of glycoprotein IIb/IIIa inhibitors.
Cardiol J. 2009;16(3):234-40.
10
The role of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention for ST elevation myocardial infarction.糖蛋白IIb/IIIa抑制剂在ST段抬高型心肌梗死直接经皮冠状动脉介入治疗中的作用。
Eur Heart J. 2005 Dec;26(23):2479-81. doi: 10.1093/eurheartj/ehi553. Epub 2005 Oct 25.